Med Page Today – by John Gever
SILVER SPRING, Md. — Two patients died 3-4 days after injections with the long-acting antipsychotic drug olanzapine pamoate (Zyprexa Relprevv), prompting an FDA investigation.
The agency has not determined whether the drug caused the fatalities. “At this time, FDA is continuing to evaluate these deaths and will provide an update when more information is available,” it said in a statement Tuesday. Continue reading “FDA Probes Deaths Linked to Long-Acting Zyprexa”